Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C14orf132 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-08 |
mRNA | ESRRG | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | NAPB | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | MYT1L | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
mRNA | GRM4 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | PGAP1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | SDK1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | ZNF493 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | SCGB2B2 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | ACTL6B | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |